Stay updated on CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Sign up to get notified when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.

Latest updates to the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page
- Check6 days agoChange DetectedThe 'Schizophrenia' condition label and the 'MedlinePlus Genetics' related topics section were removed from the page. This reduces key contextual cues about the study's condition and related resources.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded related topics Schizophrenia and MedlinePlus Genetics to the study details page.SummaryDifference0.1%

- Check20 days agoChange DetectedVersion v3.5.0 was added and the topics 'Schizophrenia' and 'MedlinePlus Genetics' were removed (Revision: v3.4.3). The core study details on the page remain unchanged.SummaryDifference0.2%

- Check27 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3; no trial content changes are indicated on the page.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded related topics Schizophrenia and MedlinePlus Genetics to the study page.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page's related topics section listing Schizophrenia and MedlinePlus Genetics was removed, reducing quick links to background information but not altering study data or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.